A CROSS-SECTIONAL STUDY OF USE OF IRON SUPPLEMENTS IN CHILDREN WITH ANEMIA

Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 6

Abstract

Objectives: Iron deficiency (ID) is the most common nutritional problem in the world and is the most common cause of childhood anemia. In this study, our aim was to find out about the state of usage of iron preparation, which is distributed free of charge by the Ministry of Health, for the infants between 4-12 months in our country, as well as detecting the awareness degree of families those who are informed about iron-deficiency anemia (IDA), prophylaxis of the drug and to determine the drug’s effectiveness. Methods: It was a cross-sectional survey. The laboratory values from the files of the children aged 1-2 those who visited our hospital’s department of pediatrics, between January 2010 to August 2013, were collected. The survey included families who have children diagnosed with IDA. Questions included about families’ sociodemographic characteristics, the state of the usage of the iron drug, how much information received in terms of the side effects-consumption period and dosage. Results: A total of 139 children were enrolled in our study. While 77.7% of the families who participated stated that (n = 108) iron medicine was prescribed other 43.2% of families stated (n = 60) was prescribed and they were informed about iron pills and IDA. 25.9% of families had received information about drug’s side effects, 74.8% of them had information about period of consumption and 77.7% said they were given information about the drug dose. The average duration of use of iron medicine was 6.98±4.52 (min: 1, max: 24) months. It has been noted that; parent’s education level, mother’s occupation, child’s gender, how the child was born and receiving information about how to use the medicine had no effects on usage of the drug in children. Nevertheless, it has been noticed that, when the families were given proper information the drug use increased and the patients compliance with medications also increased. Conclusion: We believe that, due to frequent diagnosis of anemia in children, prophylaxis iron supplementation should be continued for up to the age of two years.

Authors and Affiliations

Dr. Nayab Fatima

Keywords

Related Articles

A REVIEW ON AGRAYA AUSHADA (BEST DRUGS) IN AYURVEDA

Ayurveda is perceived as one of the most ancient and well documented system of medicine equally relevant in modern times. Its holistic approach whether for healthy individuals or for diseased ones remains unparalleled. T...

IMPACT OF TYPE AND DURATION OF INFERTILITY FOR WOMEN WITH POLYCYSTIC OVARY SYNDROME AND UNEXPLAINED INFERTILITY ON PREGNANCY OUTCOME AFTER INTRAUTERINE INSEMINATION

This study aimed to study effects of type and duration of infertility on pregnancy outcome following ovulation induction/intrauterine insemination (OI/IUI). It aimed to investigate effect of etiology of infertility on pr...

CLINICO-PATHOLOGICAL ASSESSMENT OF VASCULAR LESIONS IN COMPLICATED DIABETIC FOOT

Background: The pathological lesions of microcirculation in diabetic foot have not been previously fully studied. Identification of such lesions and their association with clinical findings in complicated diabetic foot w...

A TYPICAL REVIEW ON ANTIMICROBIAL ACTIVITY OF ACALYPHA INDICA

Aim: The aim of this article to review the antibacterial activity of acalypha indica. Medicinal herbs are moving from fringe to mainstream use with a greater number of people seeking remedies and health approaches free f...

CHRONIC VALPORIC ACID TOXICITY IN CHILDREN: OVERVIEW AND MANAGEMENT

Valproic acid is an anti-epileptic drug used to treat partial and generalized seizures, acute mania, as prophylaxis for bipolar disorder and migraine headaches. The mechanism of action of valproic acid is its ability to...

Download PDF file
  • EP ID EP664713
  • DOI -
  • Views 176
  • Downloads 0

How To Cite

Dr. Nayab Fatima (2018). A CROSS-SECTIONAL STUDY OF USE OF IRON SUPPLEMENTS IN CHILDREN WITH ANEMIA. World Journal of Pharmaceutical and Medical Research, 4(6), 87-92. https://www.europub.co.uk/articles/-A-664713